Found: 9
Select item for more details and to access through your institution.
Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritis.
- Published in:
- British Journal of Dermatology, 2022, v. 187, n. 3, p. 438, doi. 10.1111/bjd.21233
- By:
- Publication type:
- Article
Effect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three Indications.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 3, p. 935, doi. 10.1007/s40744-022-00434-z
- By:
- Publication type:
- Article
Effect of Secukinumab and Tumor Necrosis Factor Inhibitors on Humoral Response to BNT162b2 mRNA Vaccine in Patients With Spondyloarthritis Compared to Immunocompetent Controls.
- Published in:
- Journal of Rheumatology, 2024, v. 51, n. 4, p. 415, doi. 10.3899/jrheum.2023-0357
- By:
- Publication type:
- Article
Adherence and Persistence with Methotrexate in Rheumatoid Arthritis: A Systematic Review.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice.
- Published in:
- 2015
- By:
- Publication type:
- Erratum
Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice.
- Published in:
- Clinical Rheumatology, 2015, v. 34, n. 3, p. 563, doi. 10.1007/s10067-014-2857-y
- By:
- Publication type:
- Article
Treatment of Rheumatoid Arthritis With Anti-Tumor Necrosis Factor or Tocilizumab Therapy as First Biologic Agent in a Global Comparative Observational Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Evaluation of the Disease Activity Score in Twenty-Eight Joints-Based Flare Definitions in Rheumatoid Arthritis: Data From a Three-Year Clinical Trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article